Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.

Name: Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.
Published: 2010
License: Public Domain

Novartis Pharmaceuticals · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

chronic myeloid leukemia (cml), philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all), other glivec/gleevec indicated hematological disorders (hes, cel, mds/ mpn), chronic myeloid leukemia, cml, philadelphia chromosome positive, acute lymphoblastic leukemia, phglivec,, gleevec,, hypereosinophilic syndrome,, hes,, chronic eosinophilic leukemia,

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 883578
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.